These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17264824)

  • 1. Dried blood spot measurement of tacrolimus is promising for patient monitoring.
    Hoogtanders K; van der Heijden J; Christiaans M; van de Plas A; van Hooff J; Stolk L
    Transplantation; 2007 Jan; 83(2):237-8. PubMed ID: 17264824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation.
    Cheung CY; van der Heijden J; Hoogtanders K; Christiaans M; Liu YL; Chan YH; Choi KS; van de Plas A; Shek CC; Chau KF; Li CS; van Hooff J; Stolk L
    Transpl Int; 2008 Feb; 21(2):140-5. PubMed ID: 17944802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients.
    Veenhof H; Koster RA; Alffenaar JC; Berger SP; Bakker SJL; Touw DJ
    Transplantation; 2017 Jul; 101(7):1727-1733. PubMed ID: 27906832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
    Edelbroek PM; van der Heijden J; Stolk LM
    Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring.
    Veenhof H; Koster RA; Junier LAT; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2020 Sep; 58(10):1687-1695. PubMed ID: 32412437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation.
    Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE
    Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
    van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong GJ; Neef C; Stolk L
    J Pharm Biomed Anal; 2009 Nov; 50(4):664-70. PubMed ID: 19155152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
    Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
    Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots.
    Hinchliffe E; Adaway J; Fildes J; Rowan A; Keevil BG
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):106-9. PubMed ID: 23939194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of tacrolimus with the dried blood spot method.
    Hoogtanders K; van der Heijden J; Christiaans M; Edelbroek P; van Hooff JP; Stolk LM
    J Pharm Biomed Anal; 2007 Jul; 44(3):658-64. PubMed ID: 17184953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.
    Zwart TC; Gokoel SRM; van der Boog PJM; de Fijter JW; Kweekel DM; Swen JJ; Guchelaar HJ; Moes DJAR
    Br J Clin Pharmacol; 2018 Dec; 84(12):2889-2902. PubMed ID: 30176064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.
    van Boekel GA; Donders AR; Hoogtanders KE; Havenith TR; Hilbrands LB; Aarnoutse RE
    Eur J Clin Pharmacol; 2015 Jul; 71(7):811-6. PubMed ID: 25980838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.